Complement Component 8, beta Polypeptide (C8B) Peptide
-
- Target See all C8B products
- C8B (Complement Component 8, beta Polypeptide (C8B))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-C8B antibody (Catalog #: ARP44211_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- C8B (Complement Component 8, beta Polypeptide (C8B))
- Synonyms
- C82 Peptide, 4930439B20Rik Peptide, AI595927 Peptide, complement C8 beta chain Peptide, complement component 8, beta polypeptide Peptide, C8B Peptide, C8b Peptide, c8b Peptide
- Background
-
C8 beta is one of the three subunits that comprise the component 8 (C8) of the complement system. C8 participates in the formation of Membrane Attack Complex that results in the lysis of cells. Patients with C8B deficiency are prone to bacteria infection.
Alias Symbols: MGC163447
Protein Interaction Partner: C5,C8A,CLU,C5,CLU
Protein Size: 173 - Molecular Weight
- 20 kDa
- Gene ID
- 732
- NCBI Accession
- NM_000066
- UniProt
- P07358
-